Caris Life’s Life is similar over 30% on IPO display, Get the future AI of the future

The stock of caris science with its Nassdaq theater on the 5th per share and place the company over $ 8 billion.

The correct medical companies were added to 40% intussed, ends about $ 27 per share. It is a significant interest in the market interested in fluctuating marketing, which has been amazing with an ISP.

Caris life has been raising hundreds of millions of cancer and cancer in the month of cancer. According to the company, it has increased nearly $ 2 billion from 2018, and plans to use the IPO‘s procedure.

Set up in 2008, the company learned learning and learning engine and monitoring engine and monitor cancer. In an interview with Dallas morning newsPresident of President Caris Ligied President described that the company is targeted “organic growth” in search of cancer.

“Unfortunately, there is only 30% or of the patient News.

“So it has a big educational barrier, and a doctor understanding the test type we do and benefits for the patient.

AI’s occurrence has created knowledge with knowledge of knowledge about their employment prospects on their employment prospects.

But Squetzler confirms that the unnecessary intelligent specialist experts “is a life of life.

“I mean, if you see the confusion of human cells, the only true way to determine the information you can set

“And so we worked on this and publication over millions, and once you have millions of information, finding you, to find out how you want to stainner.

That makes AI “especially appropriate” in classification and cancer of the cancer of the patient, “.

SPETZLER says the company will also use the opportunity to grow regularly and extending its local footprints, while hire key positions.

“We get a lot of free space in Dallas we will build additional laboratory skills, with financial staff, sales and other sectors.